发明授权
- 专利标题： LPAAT-β inhibitors and uses thereof
- 专利标题（中）： LPAAT-β抑制剂及其用途
-
申请号： US11601513申请日： 2006-11-16
-
公开(公告)号： US07608620B2公开(公告)日： 2009-10-27
- 发明人: Lynn Bonham , Baoqing Gong , Robert E Finney , David M Hollenback , J Peter Klein , David W Leung , Scott A Shaffer , Norina M Tang , John Tulinsky , Thayer H White
- 申请人： Lynn Bonham , Baoqing Gong , Robert E Finney , David M Hollenback , J Peter Klein , David W Leung , Scott A Shaffer , Norina M Tang , John Tulinsky , Thayer H White
- 申请人地址： US WA Seattle
- 专利权人： Cell Therapeutics, Inc.
- 当前专利权人： Cell Therapeutics, Inc.
- 当前专利权人地址： US WA Seattle
- 代理机构： Seed IP Law Group PLLC
- 主分类号： C07D251/52
- IPC分类号： C07D251/52 ; C07D251/38 ; A61K31/53 ; A61P35/00
摘要：
The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-β activity.
公开/授权文献
- US20070072856A1 LPAAT-beta inhibitors and uses thereof 公开/授权日：2007-03-29
信息查询
